Cargando…
Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study
BACKGROUND: We aimed to quantify patients’ benefit-risk preferences for attributes associated with human epidermal growth factor receptor 2 (HER2)-targeted breast cancer treatments and estimate minimum acceptable benefits (MABs), denominated in additional months of progression-free survival (PFS), f...
Autores principales: | Mansfield, Carol, Botha, Willings, Vondeling, Gerard T., Klein, Kathleen, Wang, Kongming, Singh, Jasmeet, Hackshaw, Michelle D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454390/ https://www.ncbi.nlm.nih.gov/pubmed/36074320 http://dx.doi.org/10.1007/s12282-022-01394-6 |
Ejemplares similares
-
Assessment of the societal and individual preferences for fertility treatment in Australia: study protocol for stated preference discrete choice experiments
por: Botha, Willings, et al.
Publicado: (2018) -
What Features of Fertility Treatment do Patients Value? Price Elasticity and Willingness-to-Pay Values from a Discrete Choice Experiment
por: Keller, Elena, et al.
Publicado: (2022) -
Patient Preferences for Unresectable Hepatocellular Carcinoma Treatments: A Discrete-Choice Experiment
por: Li, Daneng, et al.
Publicado: (2023) -
Patients’ Preferences for Adjunctive Parkinson’s Disease Treatments: A Discrete-Choice Experiment
por: Serbin, Michael, et al.
Publicado: (2023) -
Patient Preferences for Treating “OFF” Episodes in Parkinson’s Disease: A Discrete Choice Experiment
por: Thach, Andrew, et al.
Publicado: (2021)